Importantly, the downregulation of UCHL1 leads to decreased levels of p-Akt and p-ERK, which may be a key mechanism by which UCHL1 exerts its oncogenic effect in osteosarcoma [104]. The gene discussed is UCHL1; the disease is osteosarcoma.